# Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management

> **NCT05243511** · PHASE3 · COMPLETED · sponsor: **Swing Therapeutics, Inc.** · enrollment: 275 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DEVICE:** Digital ACT
- **OTHER:** Digital Symptom Tracker

## Key facts

- **NCT ID:** NCT05243511
- **Lead sponsor:** Swing Therapeutics, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-08
- **Primary completion:** 2023-05-15
- **Final completion:** 2023-05-15
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05243511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05243511, "Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05243511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*